Pulike Biological Engineering Inc. Soars to 52-Week High Following Regulatory Milestone
Pulike Biological Engineering Inc. has achieved a 52-week high in stock price, driven by regulatory success and investor confidence, positioning the company as a leader in the veterinary bio-products market.
- Pulike Biological Engineering Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read